First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma (Q46946161)
Jump to navigation
Jump to search
scientific article published on 15 February 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma |
scientific article published on 15 February 2006 |
Statements
1 reference
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma (English)
1 reference
1 reference
Michele Baccarani
1 reference
Elena Zamagni
1 reference
Paola Tacchetti
1 reference
Patrizia Tosi
1 reference
Claudia Cellini
1 reference
Delia Cangini
1 reference
Michela Ceccolini
1 reference
Raffaele Parente
1 reference
Paola Boni
1 reference
Sante Tura
1 reference
15 February 2006
1 reference
1 reference
76
1 reference
5
1 reference
399-404
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference